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Using fluorescence microscopy we have tracked the cellular binding, surface motion, and internalization of polyarginine and polyethylenimine,
cationic ligands used for gene and protein delivery. Each ligand was complexed with a quantum dot to provide a photostable probe. Transfection
with exogenous DNAwas used to relate the observed motion to gene delivery. Cell surface motion was independent of sulfated proteoglycans, but
dependent on cholesterol. Cellular internalization required sulfated proteoglycans and cholesterol. These observations suggest that sulfated
proteoglycans act as cellular receptors for the cationic ligands, rather than only passive binding sites. Understanding the interaction of polyarginine
and polyethylenimine with the plasma membrane may assist in designing more efficient gene delivery systems.
© 2007 Elsevier B.V. All rights reserved.Keywords: Heparan sulfate proteoglycan; Cholesterol; Gene delivery; Fluorescence microscopy; Single particle tracking; Quantum dot1. Introduction
Cationic polymers and peptides are becoming increasingly
important as vectors to deliver genes, proteins, and other mole-
cular cargo to cells. Two promising vectors are polyarginine (PA)
and polyethylenimine (PEI) [1,2]. These vectors can be conju-
gated to proteins and other large molecules or electrostatically
complexed with anionic DNA [3–8]. The net charge of both the
PA and PEI complexes is positive, allowing the complex to bind
to negatively charged molecules on the cell surface. Following
binding, these cationic complexes undergo diffusive motion on
the cell surface before internalization via endocytosis [9–13].
Themotion of PA andPEI on the cell surface andwithin the cell
can be observed directly using fluorescence microscopy and a
suitable fluorescent probe. Quantum dots provide bright, photo-
stable probes that can be combinedwith PA or PEI to form a highly
fluorescent complex. The use of quantum dots as probes allows for
long-time, continuous tracking of individual complexes. In this⁎ Corresponding author. Tel.: +1 404 385 3125; fax: +1 404 385 6057.
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doi:10.1016/j.bbamcr.2007.07.009study, cells were treated with drugs to disrupt cell surface pro-
teoglycans, the binding site for these ligands [12,14–16], and
cholesterol, essential for the dynamics of the plasma membrane.
Cationic ligand-quantum dot complexes were tracked under these
conditions to determine the effect on motion and internalization.
To this end, fluorescence microscopy provides an ideal method to
isolate and observe individual steps of the internalization process.
Transfectionwith exogenousDNAwas used to relate the observed
motion to the overall process of gene delivery. Although the
quantumdot complexes are smaller than the PEI–DNAcomplexes
used for gene delivery, recent work has shown that both complexes
utilize the same endocytic pathway [16].
2. Materials and methods
2.1. Cell culture
BS-C-1 cells (ATCC) were maintained in a 5% carbon dioxide environment
in Dulbecco's modified Eagle's medium (Invitrogen) with 10% (v/v) fetal
bovine serum at 37 °C. Cells were passaged every 3 days. For fluorescence
imaging, cells were cultured to 80% confluency in 60 mm glass-bottomed Petri
dishes (MatTek). Imaging experiments were carried out in phenol red-free
minimum essential medium (Invitrogen).
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Quantum dots (QDs, Invitrogen) with 705 nm emission were conjugated
to either biotin-tagged polyarginine (PA–QDs, R=8, as determined by mass
spectrometry), according to the manufacturer's instructions (QTracker Protocol),
or polyethylenimine (22 kDa, linear, jetPEI, Bridge Bioscience Corporation) at a
ratio of 3.75×104 nitrogen PEI residues to QDs. PEI was electrostatically bound
to streptavidin-conjugated quantum dots (PEI–QDs), an interaction that
remained intact throughout the duration of the experiment, described below. In
comparison to standard fluorescent dyes for DNA, the QDs provide a brighter,
longer-lived fluorescent probe. As described below, QDs that were not com-
plexed with PA or PEI were not internalized by the cell. For imaging, both PA–
and PEI–QDs were added to the cell culture at a concentration of 100 pM.
The hydrodynamic radii of the QD complexes was measured with dynamic
light scattering (DLS, Protein Solutions) using a cummulant analysis method
(Protein Solutions). Measurements were carried out at 20 °C and 37 °C and
averaged over a minimum of 20 points with 10 s integration times. Streptavidin-
QDs, the basic QD structure for each of the complexes, measured 14.1±3.8 nm at
20 °C and 16.1±6.5 nm at 37 °C. This is in good agreement with the 15.7±3.7 nm
hydrodynamic radius measured by N.C. Cady et al. at 25 °C [17]. PEI–QDs
measured 27.4±9.4 nm at 20 °C and 28.7±9.7 nm at 37 °C. Time-dependent
measurements showed that the radius of the PEI–QDs, measured at 20 °C,
increased from 27.4±9.4 immediately following the 30-min room temperature
incubation required for preparation to 29.0±13.3 nm following another 60 min
incubation at room temperature. This indicates that the PEI–QD complexes
remained intact and did not aggregate over a 1 h period.Wewere unable to useDLS
to measure the radius of the PA–QD complexes. Invitrogen specifies a radius of
11 nm, measured by size exclusion chromatography. Despitemuch discussionwith
Invitrogen, we have been unable to resolve the reason for the difficulty of DLS
measurements. Based on ourmeasurement of streptavidin–QDs and PEI–QDs, we
expect the hydrodynamic radius of the PA–QDs to be approximately 20 nm.
2.3. PEI–DNA conjugation and gene delivery
In addition to QDs, PEI was also complexed with DNA to measure the
efficiency of gene delivery. In this case, PEI was complexedwithβ-galactosidase
DNA (Promega) with a ratio of 8 PEI nitrogen residues to 1 DNA phosphate
residue (N:P=8) in 200 μL of 150 μMNaCl as specified by the jetPEI protocol.
The hydrodynamic radii of the PEI–DNA complexes was 311.2±164.1 nm,
measured at 37 °C. Hydrodynamic radii of PEI–DNA complexes are very
sensitive to salt concentrations during preparation and previous measurements
range from 50 nm [18] to 236 nm [19]. Despite the larger size of the PEI–DNA
complexes, previous work has shown that the same endocytic pathway is used by
PEI–siRNA and DNA complexes and PA–QD complexes [16].
For measurements of transfection efficiency, a total of 3 μg DNA, complexed
with PEI, was added to each well of a 6-well plate. Cells were incubated with the
PEI–DNA for 2 h atwhich time 50μg/mL dextran sulfate (9000–20,000Da, Sigma-
Aldrich)was added to eachwell to dissociate the PEI from theDNA thereby stopping
transfection. This allowed 2 h for internalization of the PEI–DNA complex. Any
complexes remaining on the cell surface were dissociated and inactivated.
The dissociation with dextran sulfate has also been observed using two-color
fluorescence imaging and ethidium bromide staining (data not shown). Transfection
efficiency was recorded at 24 h by measuring the expression of β-galactosidase via
the conversion of o-nitrophenyl-β-D-galactoside to o-nitrophenol (Promega,
β-galactosidase assay) and normalized against the concentration of cell lysate. As
a control, cells in which PEI–DNAwas added simultaneously with dextran sulfate
showed 0% transfection efficiency.
Unfortunately, PEI–DNA, with DNA labeled with intercalating dyes such
as TOTO-3 (Invitrogen), and PEI-siRNA, with the siRNA labeled with Cy5
(Dharmacon), were not sufficiently bright and photostable for the continuous,
long time tracking necessary to characterize motion on the cell surface.
2.4. Drug treatments
The incubation of cells with sodium chlorate, 80 mM for 24 h prior to
experiments, was used to inhibit ATP-sulfurylase thereby preventing the
sulfation of proteoglycans [20]. This method has been used previously in thestudy of gene delivery vectors and appears to be specific in the targeting of
proteoglycans [14,21]. The efficiency of this treatment was tested with an
antibody against heparan sulfate proteoglycans [16]. No changes in cell mor-
phology were observed following sodium chlorate treatment and, as a control to
test the viability of non-proteoglycan binding sites, binding of transferrin was
unaffected [16]. After the 24 h pretreatment, sodium chlorate was removed from
the medium immediately prior to the addition of PA–QDs or PEI–DNA.
Methyl-β-cyclodextrin (MβCD) was used to sequester cholesterol from the
plasma membrane [22]. Cells were pretreated with 2 mM MβCD for 30 min
prior to experiments. All drugs were purchased from Sigma-Aldrich.
2.5. Measurement of internalization
Internalization of PA–QDs was measured using software written to count the
number of QDs present in cells following the dextran sulfate treatment described
below. The numbers reported for internalization measurements reflect the
number of QDs averaged over 10–20 cells. For each drug treatment, individual
cells showed approximately the same extent of internalization meaning that the
drug treatments affected all cells equally. Large aggregates, N1 μm, of PA–QDs
were occasionally observed on the cell surface and these were not included in the
analysis. The identification of a single QD is typically determined by the
observation of blinking as it is unlikely that multiple quantum dots will each
enter a dark state simultaneously. While blinking is observed for PA–QDs on the
cell surface, internalized PA–QDs show reduced blinking, likely due to the
formation of small aggregates of PA–QDs within individual endosomes [23]. It
is unclear if the formation of small aggregates occurs immediately prior to
internalization, possibly through a clustering mechanism, or due to rapid fusion
of the initial endosomes.
2.6. Removal of cationic ligands-quantum dots from the cell surface
Imaging did not exceed 10 min following addition of PA–QDs to the cell
culture. At this time the majority of quantum dots were not yet internalized by
the cell and remained on the cell surface. The extent of internalization was
measured using a high concentration, 100 μg/mL, of anionic dextran sulfate to
remove quantum dots from the cell surface. The addition of this high con-
centration of dextran sulfate dissociated quantum dots from the membrane
allowing them to be rinsed from the cell culture, as tested by cold-binding
experiments at 4 °C. Any PA–QDs that were internalized remained visible after
rinsing. Using this method, we measured that 13% of the PA–QDs were
internalized within the period images were collected. Internalized PA–QDs
displayed rapid, directed motion indicative of microtubule-dependent transport
and were not included in the cell surface motion analysis [24,25].
2.7. Fluorescence imaging
PA– and PEI–QDs were excited with a 532 nm diode laser (Crystalaser).
A polychroic beamsplitter (Chroma) designed to reflect at 520–550 nmwas used to
direct the laser line onto the cells. The fluorescent emission at 705 nmwas collected
by an oil-immersion objective (N.A.=1.45, 60X, Olympus) using an IX70
Olympus microscope in an epifluorescent configuration and imaged onto a CCD
camera (Roper Scientific, CoolSnap HQ). Leak through of the 532 nm laser line
was removed with a 665 nm longpass filter (Chroma). Images were recorded at a
rate of 2Hz for a period of 10min. Experimentswere conducted at 37 °C and 20 °C.
Temperature was controlled by a water bath-heated stage plate and objective collar.
2.8. Data analysis
A time series of fluorescence images was used to determine the speed of the
PA– or PEI–QDs on the cell surface. PA–QDs are used as an example to explain
the method. Data analysis began with the random selection of 7–10 PA–QD
complexes on the surface of each cell. These randomly chosen PA–QD
complexes were tracked over a period of 10 min and the distance traveled within
each 500 ms period was recorded and converted to speed. The speed of the PA–
QD at each step was used to construct a probability distribution in which the
x-axis shows the speed of each step and the y-axis shows the percent of PA–QDs
with a specific speed within the 500-ms time step. It is important to note that this
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a collection of PA–QDs randomly distributed on the cell surface. Rather than
selecting a single PA–QD as an example, we examined multiple, randomly
chosen, PA–QDs as a population. While we estimate that 2000 steps are suf-
ficient for a representative distribution, larger data sets were collected for PA–
QDs on untreated cells, as these data were used as a point of comparison for all
other experiments. The distribution was truncated at 1.5 μm/s for visualization.
All values were included in the analysis.
3. Results and discussion
3.1. Motion of polyarginine and polyethylenimine-quantum dots
on the cell surface
Polyarginine–quantum dots (PA–QDs) added to cells at
37 °C showed a distribution with a mean of .41 μm/s and a mode
of 0.08 μm/s (Fig. 1A). The distribution constructed for PA–
QDs at 37 °C consists of speeds recorded from 24 cells with a
total of 23,247 steps. As described above, this motion occurred
on the cell surface and did not show any directionality indicativeFig. 1. Motion of cationic ligands on the cell surface. (A) Distribution of speeds for P
comparison in the following figures. (B) At 20 °C the distribution of PA–QD speeds is
show a similar distribution to that of PA–QDs (gray line). (D) In the absence of PAof microtubule-dependent motion. The distribution observed for
PA–QDs at 37 °C serves as a comparison for subsequent
measurements. The observed motion was temperature-depen-
dent. At 20 °C, a temperature at which the mobility of the plasma
membrane is reduced, motion continued on the cells surface, but
the distribution of speeds narrowed and shifted to slower speeds
with a mean of 0.30 μm/s and a mode of 0.04 μm/s (Fig. 1B).
Conjugation of quantum dots with PEI (PEI–QDs), instead of
PA, resulted in a similar distribution to that of PA–QDs (Fig. 1A
and C, both 37 °C). In the absence of PA or PEI, QDs bound to
the plasma membrane and showed limited motion (Fig. 1D,
37 °C), similar to that of cells at 20 °C. Without conjugation to a
cationic ligand the QDs were not internalized by the cell.
3.2. Disrupting proteoglycans does not inhibit motion on the
cell surface
Proteoglycans, specifically heparan sulfate proteoglycans,
have been shown to be necessary for cellular internalization ofA–QDs at 37 °C. The gray line is a direct plot of the data points and is used for
shifted to slower speeds as compared to 37 °C (gray line). (C) PEI–QDs at 37 °C
or PEI, QDs show limited motion and are not internalized by the cell, 37 °C.
Fig. 3. Plasma membrane cholesterol is necessary for motion. The use of MβCD
to sequester cholesterol resulted in a PA–QD distribution similar to that
observed at 20 °C (dashed gray line) in comparison to 37 °C (solid gray line).
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and polyethylenimine [12,14–16,26]. The sulfate groups of the
proteoglycans provide a dense region of negative charge on the
cell surface, an ideal binding site for cationic ligands [27]. To
test the role of proteoglycans in cell surface motion, PA–QDs
were tracked on the cell surface in the absence of negatively
charged sulfate groups following sodium chlorate treatment.
Sodium chlorate inhibits the activity of ATP–sulfurylase, an
enzyme that leads to the sulfation of proteoglycans in cells [20].
PA–QDs were added to cells immediately before imaging.
Importantly, the medium was not replaced after the PA–QDs
were added to the cells, i.e. the cells were not washed.
Following addition to the sodium chlorate treated-cells,
PA–QDs bound to and moved on the cell surface (Fig. 2A).
Surprisingly, motion on the cell surface showed strong
similarities to that of untreated cells. While it had been expected
that the removal of the main binding site would prevent binding
or radically alter motion, the distribution showed a similar mean,
0.44 μm/s, an increased mode, 0.11 μm/s, and a broader
distribution with no observed decrease in the number of
PA–QDs bound to the cells. Qualitatively, this distribution
reflects a slight increase in the motion of PA–QDs on the cell
surface. Within the 10 min observation no differences wereFig. 2. The disruption of proteoglycans does not inhibit motion, but does affect
binding. (A) Distribution of PA–QD speeds following sodium chlorate
treatment for the removal of sulfated proteoglycans, 37 °C. The gray line
shows the distribution for untreated cells. (B) PA–QD binding after washing of
sodium chlorate-treated (NaClO3) and control cells. Scale bars: 10 μm. The
same effect is seen for PEI–QDs.observed in the lengths of the trajectories for control and sodium
chlorate-treated cells.
3.3. Disrupting proteoglycans prevents stable binding and
internalization
While the motion of the PA–QDs on the cell surface was
slightly increased by the removal of the proteoglycan sulfate
groups, the permanent binding and internalization of PA–QDs
was ultimately blocked by the sodium chlorate treatment. For
control cells, PA–QDs and PEI–QDs were stably bound to the
cell surface meaning the ligands remained bound to the cells
following replacement of the cell culture medium (Fig. 2B,
Control). In comparison, sodium chlorate treatment resulted in
the dissociation of PA–QDs and PEI–QDs from the cell surface
following replacement of the cell culture medium (Fig. 2B,
NaClO3). These results suggest a weak interaction between PA
or PEI and a secondary binding site on the cell surface. There
are a number of candidates for the weaker binding site res-
ponsible for binding in the absence of sulfate groups as a range
of anionic ligands are present on the cell surface that may bind
to PA or PEI. The observation that the distribution of motion is
not strongly affected by the sodium chlorate treatment suggests
that the weaker binding site may be another species of pro-
teoglycan with similar cell surface dynamics, possibly remain-
ing sulfated due to the selectivity of the sodium chlorate
treatment [28].
Despite weak binding to the cell surface, internalization of
the PA–QDs and PEI does require sulfated proteoglycans on the
cell surface. This was tested in two ways. First, direct imaging
was used in combination with a dextran sulfate wash. The
dextran sulfate wash removed PA–QDs from the cell surface
while PA–QDs that have been internalized were unaffected.
One hour after the addition of PA–QDs to the cell medium, cells
were washed with dextran sulfate and imaged. The internali-
zation for untreated cells was normalized to 100%. In com-
parison, the majority of PA–QDs were removed from sodium
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compared to the control cells. Second, the entire gene delivery
process was tested by complexing PEI with β-galactosidase
DNA and measuring the expression of β-galactosidase 24 h
after addition to cell culture. The transfection efficiency for
untreated cells is normalized to 100%. In comparison, sodium
chlorate treated cells showed a 53% transfection efficiency. The
internalization of a fluid phase marker, 10,000 Da TMR-labeled
dextran (Invitrogen), was not inhibited by the sodium chlorate
treatment.
3.4. Sequestering cholesterol inhibits motion on the cell surface
Methyl-β-cyclodextrin (MβCD) sequesters cholesterol from
the plasma membrane reducing the mobility of the plasma
membrane [22]. Following a 30 min pretreatment with 2 mM
MβCD, cells were imaged at 37 °C using the methods described
above. MβCD treatment resulted in a very different distribution
of speeds in comparison to untreated cells (Fig. 3). The mean
shifted downward to 0.27 μm/s and the distribution narrowed.
The distribution for MβCD treated cells at 37 °C was similar to
that for untreated cells at 20 °C (dashed curve).
3.5. Sequestering cholesterol prevents internalization
As with sodium chlorate, the internalization of PA–QDs in the
presence of MβCD was measured by direct imaging and PEI-
mediated gene delivery was determined by measuring transfec-
tion efficiency for PEI complexed with β-galactosidase DNA.
Direct visualization of PA–QDs showed a 45% decrease for
internalization and 35% decrease of β-galactosidase expression.
This decrease in internalization was expected considering the
wide range of inhibitory effects observed for MβCD treatment.
Sequestering cholesterol with MβCD has been shown to have an
inhibitory effect on multiple internalization pathways including;
clathrin-, caveolin-, and lipid raft-mediated pathways, as well as
the mobility of non-raft proteins [29–32]. Additionally, it is
possible that “clustering” of the proteoglycans is necessary for the
internalization of PA and PEI [33]. In this case, the inhibited
mobility of the membrane would prevent clustering and block the
internalization of these ligands. In short, MβCD treatment will
block many internalization pathways and is used as a control to
demonstrate the reduced motion and internalization associated
with cholesterol sequestration.
In summary, we have used fluorescence microscopy to track
the binding, cell surface motion, and internalization of the
cationic ligands PA and PEI using quantum dots as fluorescent
probes. The disruption of the sulfate groups of the proteogly-
cans revealed a surprising interaction of PA and PEI with the
cell surface. The removal of the sulfate groups did not prevent a
weak binding of the PA or PEI to the cell surface and did not
inhibit the motion of the PA–QDs on the cell surface. Despite
the weak interaction with the cell surface and a similar dis-
tribution of speeds, the internalization of PA–QDs and PEI–
DNA was blocked in the absence of the sulfate groups. As
expected, the removal of cholesterol inhibits both motion and
internalization. The results obtained with the direct tracking ofindividual PA– and PEI–QDs, supported by transfection stu-
dies, are most significant in understanding the importance of
sulfated proteoglycans for internalization, in addition to
binding, of cationic gene delivery vectors. Unlike ligands
such as transferrin or epidermal growth factor, synthetic ligands
used for gene delivery do not have conjugate cellular receptors.
The observation that PA and PEI complexes bind to the cell
surface and exhibit similar dynamics in the absence of sulfated
proteoglycans, but cannot be internalized, suggests that sulfated
proteoglycans may act as true receptors for PA and PEI [16,33].
Overall, understanding the interaction of PA and PEI with the
cell surface, especially in terms of receptor interactions, may
assist in designing more efficient gene delivery systems and also
provides a general model for the interaction of synthetic ligands
with the cell surface.
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